CORRECTION article

Front. Pharmacol., 12 December 2024

Sec. Renal Pharmacology

Volume 15 - 2024 | https://doi.org/10.3389/fphar.2024.1532797

Corrigendum: Endoglin aggravates peritoneal fibrosis by regulating the activation of TGF-β/ALK/Smads signaling

  • 1. Department of Nephrology, Shandong Provincial Hospital, Shandong University, Jinan, China

  • 2. Department of Nephrology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China

In the published article, there was an error in the Funding statement. Some information were erroneously omitted from the statement. The original statement stated: This research was funded by National Science Foundation for Young Scholars of China (Grant Nos. 81500584 and 81200530) and the Science and Technology Development Plan Program of Medicine and Health of Shandong Province (No. 202103050761). The correct Funding statement appears below.

Statements

Funding

The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. This research was funded by National Science Foundation for Young Scholars of China (Grant Nos 81500584 and 81200530), the Science and Technology Development Plan Program of Medicine and Health of Shandong Province (No. 202103050761), Jinan Science and Technology Development Plan - Clinical Medicine Technology Innovation Plan (No. 202225049) and Young Scientist Fund Training Program of Shandong First Medical University (Shandong Academy of Medical Sciences) (No. 202201-062).

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

endoglin, peritoneal fibrosis, angiogenesis, EMT, TGF-β/ALK/Smads

Citation

Huang Q, Xiao R, Lu J, Zhang Y, Xu L, Gao J, Sun J and Wang H (2024) Corrigendum: Endoglin aggravates peritoneal fibrosis by regulating the activation of TGF-β/ALK/Smads signaling. Front. Pharmacol. 15:1532797. doi: 10.3389/fphar.2024.1532797

Received

22 November 2024

Accepted

25 November 2024

Published

12 December 2024

Approved by

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Volume

15 - 2024

Updates

Copyright

*Correspondence: Jing Sun, ; Haiping Wang,

†These authors have contributed equally to this work and share first authorship

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics